Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7599 USD | -0.01% | -9.06% | -43.71% |
05-15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-43.71% | 2.89M | |
-3.85% | 187B | |
+0.16% | 109B | |
-3.04% | 69.22B | |
-6.45% | 46.36B | |
+13.54% | 46.19B | |
+8.48% | 42.44B | |
+18.60% | 30.84B | |
+19.69% | 25.73B | |
-8.64% | 23.3B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- INVO Bioscience, Inc. Elects Trent Davis to the Board of Directors